(Q45362053)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

The long and the short of interferon-gamma-inducible protein 10 in hepatitis C virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Andrew R. Lloyd

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Amany Zekry

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Geoffrey W McCaughan

3

0 references

language of work or name

English

0 references

publication date

1 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

1875-1879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22038789%20AND%20SRC:MED&resulttype=core&format=json

Chemokines in the immunopathogenesis of hepatitis C infection

15 January 2020

cites work

1 reference

Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics

21 January 2018

1 reference

Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease

21 January 2018

1 reference

Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

21 January 2018

1 reference

Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.

21 January 2018

1 reference

Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.

21 January 2018

1 reference

Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C.

21 January 2018

1 reference

The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.

21 January 2018

1 reference

Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

21 January 2018

1 reference

Histological features predictive of liver fibrosis in chronic hepatitis C infection

21 January 2018

1 reference

Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy.

21 January 2018

1 reference

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C

21 January 2018

1 reference

Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

21 January 2018

1 reference

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

21 January 2018

1 reference

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

21 January 2018

1 reference

Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy

21 January 2018

1 reference

Interferon signaling and treatment outcome in chronic hepatitis C

21 January 2018

1 reference

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

21 January 2018

1 reference

Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family

21 January 2018

1 reference

The dipeptidyl peptidase IV family in cancer and cell biology.

21 January 2018

1 reference

Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance

21 January 2018

1 reference

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

21 January 2018

1 reference

21 January 2018

1 reference

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

21 January 2018

1 reference

Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis

21 January 2018

1 reference

An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials

21 January 2018

1 reference

Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice

21 January 2018

1 reference

Proteolytic processing of chemokines: implications in physiological and pathological conditions.

21 January 2018

1 reference

Altered zonal expression of the CD26 antigen (dipeptidyl peptidase IV) in human cirrhotic liver

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Molecular characterization of dipeptidyl peptidase activity in serum

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Increased serum levels of dipeptidyl peptidase IV (CD26) in rats undergoing liver regeneration

1 reference